Flortaucipir F-18 Completed Phase 4 Trials for Whole Body Imaging / Brain Imaging Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic4
clinicaltrials.gov IdentifierTitleDrugs
NCT04417998
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction